Dechra Pharmaceuticals PLC Holding(s) in Company (6554X)
February 23 2017 - 03:53AM
UK Regulatory
TIDMDPH TIDMAV.
RNS Number : 6554X
Dechra Pharmaceuticals PLC
23 February 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or Dechra Pharmaceuticals
the underlying issuer plc
of existing shares to which
voting rights are
attached: (ii)
----------------------------------------------------------------- --------------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
---------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights
-------------------------------------------------------------------- -----------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
-------------------------------------------------------------------- -----------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
-------------------------------------------------------------------- -----------------------------
An event changing the breakdown of voting rights
-------------------------------------------------------------------- -----------------------------
Other (please
specify):
----------------------------------------------------------- ------- -----------------------------
3. Full name of person(s) Aviva plc & its subsidiaries
subject to the
notification obligation:
(iii)
------------------------------------------------------------- ------------------------------------
4. Full name of shareholder(s) Registered Holder:
(if different from 3.):(iv)
Chase (GA Group) Nominees
Limited
2,070,968*
Chase Nominees Limited
21,988*
HSBC Global Custody Nominee
(UK) Limited
494,541*
Street Nominees Limited
227,684*
Available Upon Request
7,446*
* denotes direct interest
------------------------------------------------------------- ------------------------------------
5. Date of the transaction 21 February 2017
and date on
which the threshold is
crossed or
reached: (v)
------------------------------------------------------------- ------------------------------------
6. Date on which issuer 22 February 2017
notified:
------------------------------------------------------------- ------------------------------------
7. Threshold(s) that is/are <3% to >3% Change at Direct
crossed or Interest Level
reached: (vi, vii)
------------------------------------------------------------- ------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
-------------- ------------------------------ --------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
-------------- --------------- ------------- ----------- ------------------------- ----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
-------------- -------------- ------------ ----------- ---------- ------------- ------- -------------
Ordinary
Shares
Below Below Not Not
GB0009633180 Threshold Threshold 2,822,627 2,822,627 Disclosable 3.03% Disclosable
--------------- ------------- ----------- ---------- ------------- ------- -------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument
is
exercised/
converted.
--------------- --------------- ------------------------- ------------------------- ----------------------
RIGHT TO 159,637 *
RECALL
LOANED SHARES N/A N/A * Direct Interest 0.17%
--------------- --------------- ------------------------- ------------------------- ----------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
-----------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
-----------------------------------------------------------------------------------------------
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date Conversion rights instrument rights (xix,
(xvii) period refers to xx)
(xviii)
------------------ --------- ----------- ------------ ------------------- ----------------
Nominal Delta
------------------ --------- ----------- ------------ ------------------- -------- ------
Total (A+B+C)
------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------ ----------------------------
2,982,264 3.20%
------------------------ ----------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
--------------------------------------------------------------------
The voting rights are managed and controlled by Aviva
Investors Global Services Limited and Friends Provident
International Limited, with the following chains of
controlled undertakings:-
Aviva Investors Global Services Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Aviva Investors Holdings Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
* Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Friends Provident International Limited:
* Aviva plc (Parent Company)
* Aviva Group Holdings Limited (wholly owned subsidiary
of Aviva plc)
* Friends Provident International Limited (wholly owned
subsidiary of Aviva Group Holdings Limited)
Proxy Voting:
--------------------------------------------------------------------
10. Name of the proxy holder: See Section 4
------------------------------------------------ ------------------
11. Number of voting rights proxy
holder will cease
to hold:
------------------------------------------------ ------------------
12. Date on which proxy holder will
cease to hold
voting rights:
------------------------------------------------ ------------------
13. Additional information: Figures are based on a total
number of voting rights of
93,059,190 as per the Company's
Total Voting Rights Announcement
of 31 January 2017.
------------------------------- ----------------------------------
14. Contact name: Neil Whittaker, Aviva plc
------------------------------- ----------------------------------
15. Contact telephone number: 01603 684420
------------------------------- ----------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLDMGZZRFNGNZG
(END) Dow Jones Newswires
February 23, 2017 03:53 ET (08:53 GMT)
Aviva (LSE:AV.)
Historical Stock Chart
From Feb 2024 to Mar 2024
Aviva (LSE:AV.)
Historical Stock Chart
From Mar 2023 to Mar 2024